Pfizer has confirmed the launch of a major agency review that will include creative, PR, digital and possibly other segments, but has denied speculation that it's looking to consolidate its $1.2 billion marketing budget. "The intent is not to consolidate," said Ray Kerins, VP-worldwide communications at Pfizer. "The intent is to understand our agency partners better. This is not a full blanket sweep of all the agencies."

Related Summaries